Study Of The Efficacy And Safety Of SU-014813 In Patients With Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Neoplasms
Interventions: DRUG: SU014813
Sponsor: Pfizer